Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis. (Q39941738)
Jump to navigation
Jump to search
scientific article published on 9 September 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis. |
scientific article published on 9 September 2008 |
Statements
Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis (English)
Catherine Wilson
Colin Purcell
Angela Seaton
Olabode Oladipo
Pamela J Maxwell
Joe M O'Sullivan
Richard H Wilson
Patrick G Johnston
9 September 2008